you mean reference 1 about predictive power statistical model? OK great. So what? Comes back to the same question: what was the pre-planned futility threshold? Did they need to do better than placebo by at least 5%, at least 10%, at least 25%, at least 50% etc ?? Did they need to at least match what their phase 2 showed?
It's a fair question surely. Why are you so defensive?
Ann: Dimerix Successfully Passes Efficacy Interim Analysis, page-60
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.0¢ |
Change
0.050(10.2%) |
Mkt cap ! $296.8M | |||
| Open | High | Low | Value | Volume |
| 50.0¢ | 55.0¢ | 49.5¢ | $3.604M | 6.829M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5607 | 53.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.0¢ | 29997 | 1 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
54.0¢ |
Change
0.050 ( 9.31 %) |
||||
| Open | High | Low | Volume | ||
| 50.0¢ | 55.0¢ | 49.5¢ | 4345620 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| DXB (ASX) Chart |